1MRKX:BIT
Merck & Co.
128,18 €
arrow_downward
-0,59%(-0,76) 1 d.
2. 10., 17:26:00 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Trefis
·
pred 7 hodinami
How Has Merck’s Story Changed?
MarketBeat
·
pred 9 hodinami
Curated Wealth Partners LLC Sells 127,541 Shares of Merck & Co., Inc. $MRK
StreetInsider
·
pred 13 hodinami
Form 25-NSE Merck & Co., Inc. Filed by: NEW YORK STOCK EXCHANGE LLC
Yahoo Finance
·
pred 15 hodinami
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
Profil
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia